For example, DKK3 mRNA was found to be downregulated in over 60% of NSCLC patients36, 37, whereas the proportion of patients with a hypermethylated DKK3 promoter was found to be l<20% (refs 17, 38, 39). Here, DKK3 is linked to non-small cell lung carcinoma.